Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael T. Jaklitsch, M.D.

Co-Author

This page shows the publications co-authored by Michael Jaklitsch and Raphael Bueno.
Connection Strength

5.523
  1. Thoracoscopic surgery in elderly lung cancer patients. Crit Rev Oncol Hematol. 2004 Feb; 49(2):165-71.
    View in: PubMed
    Score: 0.290
  2. Postoperative empyema after pleurectomy decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2021 Oct 04.
    View in: PubMed
    Score: 0.247
  3. Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients. Ann Surg. 2020 Dec 03.
    View in: PubMed
    Score: 0.233
  4. Impact of Neoadjuvant Chemoradiation on Adverse Events After Bronchial Sleeve Resection. Ann Thorac Surg. 2021 09; 112(3):890-896.
    View in: PubMed
    Score: 0.232
  5. Risk of Urinary Recatheterization for Thoracic Surgical Patients with Epidural Anesthesia. J Surg Res (Houst). 2020; 3(3):163-171.
    View in: PubMed
    Score: 0.226
  6. Image-guided video-assisted thoracoscopic resection (iVATS): Translation to clinical practice-real-world experience. J Surg Oncol. 2020 Jun; 121(8):1225-1232.
    View in: PubMed
    Score: 0.222
  7. Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 Oct; 160(4):1064-1073.
    View in: PubMed
    Score: 0.220
  8. The effect of a lifestyle risk reduction intervention on lifestyle adherence and health-related quality of life in nonsmall cell lung cancer survivors: Feasibility study outcomes. Psychooncology. 2019 04; 28(4):920-923.
    View in: PubMed
    Score: 0.206
  9. Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Surg Oncol Clin N Am. 2016 07; 25(3):567-84.
    View in: PubMed
    Score: 0.172
  10. Early Surgical Outcomes of En Bloc Resection Requiring Vertebrectomy for Malignancy Invading the Thoracic Spine. Ann Thorac Surg. 2016 Jan; 101(1):231-6; discussion 236-7.
    View in: PubMed
    Score: 0.161
  11. Image-guided video assisted thoracoscopic surgery (iVATS) - phase I-II clinical trial. J Surg Oncol. 2015 Jul; 112(1):18-25.
    View in: PubMed
    Score: 0.159
  12. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg. 2011 Oct; 92(4):1202-7.
    View in: PubMed
    Score: 0.123
  13. The role of extrapleural pneumonectomy in the management of pleural cancers. J Clin Oncol. 2009 May 20; 27(15_suppl):7577.
    View in: PubMed
    Score: 0.105
  14. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009 Nov; 66(2):218-25.
    View in: PubMed
    Score: 0.104
  15. VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. Int J Surg. 2008 Apr; 6(2):110-4.
    View in: PubMed
    Score: 0.095
  16. Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations. Ann Thorac Surg. 2007 Mar; 83(3):1129-33.
    View in: PubMed
    Score: 0.090
  17. Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program. Ann Thorac Surg. 2007 Feb; 83(2):425-31; discussion 432.
    View in: PubMed
    Score: 0.089
  18. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. Ann Thorac Surg. 2006 Mar; 81(3):1034-42.
    View in: PubMed
    Score: 0.084
  19. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006 Feb; 131(2):438-46.
    View in: PubMed
    Score: 0.083
  20. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest. 2005 Nov; 128(5):3255-60.
    View in: PubMed
    Score: 0.082
  21. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005 Jul; 128(1):237-45.
    View in: PubMed
    Score: 0.080
  22. Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast. J Cell Mol Med. 2005 Jul-Sep; 9(3):662-9.
    View in: PubMed
    Score: 0.080
  23. Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events. J Cell Mol Med. 2005 Apr-Jun; 9(2):387-97.
    View in: PubMed
    Score: 0.079
  24. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 01; 23(7):1530-7.
    View in: PubMed
    Score: 0.078
  25. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004 Nov; 78(5):1774-6.
    View in: PubMed
    Score: 0.076
  26. Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1. Ann Thorac Surg. 2004 Aug; 78(2):450-7.
    View in: PubMed
    Score: 0.075
  27. High risk of brain metastases in surgically staged IIIA NSCLC patients treated with surgery, chemotherapy and radiation. J Clin Oncol. 2004 Jul 15; 22(14_suppl):7173.
    View in: PubMed
    Score: 0.075
  28. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest. 2004 Jun; 125(6):2175-81.
    View in: PubMed
    Score: 0.074
  29. A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev. 2003 Sep; 12(9):905-10.
    View in: PubMed
    Score: 0.070
  30. Endovascular stent-graft repair of a pulmonary artery-bronchial fistula. J Vasc Interv Radiol. 2003 Jul; 14(7):929-32.
    View in: PubMed
    Score: 0.070
  31. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst. 2003 Apr 16; 95(8):598-605.
    View in: PubMed
    Score: 0.069
  32. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis. 2002 Jun; 23(6):1017-24.
    View in: PubMed
    Score: 0.065
  33. Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. Oncol Rep. 2002 May-Jun; 9(3):631-4.
    View in: PubMed
    Score: 0.064
  34. Formal Military Civilian Affiliations are a Template for Low Military Cardiothoracic Surgery Volume. Ann Thorac Surg. 2021 Sep 28.
    View in: PubMed
    Score: 0.062
  35. Risk factors for prolonged air leak and need for intervention following lung resection. Interact Cardiovasc Thorac Surg. 2021 Sep 18.
    View in: PubMed
    Score: 0.062
  36. Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointest Endosc. 2001 Sep; 54(3):368-72.
    View in: PubMed
    Score: 0.061
  37. Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. J Thorac Cardiovasc Surg. 2001 Apr; 121(4):657-67.
    View in: PubMed
    Score: 0.060
  38. Impact of radial margins after esophagectomy for esophageal cancer. Eur J Surg Oncol. 2021 Sep; 47(9):2313-2322.
    View in: PubMed
    Score: 0.059
  39. Chemotherapy and Surgical Resection for N1 Positive Non-small Cell Lung Cancer: Better Than Expected Outcomes. Semin Thorac Cardiovasc Surg. 2021 Feb 16.
    View in: PubMed
    Score: 0.059
  40. Adjuvant therapy following induction therapy and surgery improves survival in N2-positive non-small cell lung cancer. J Surg Oncol. 2021 Feb; 123(2):579-586.
    View in: PubMed
    Score: 0.058
  41. Outcomes of superior segmentectomy versus lower lobectomy for superior segment Stage I non-small-cell lung cancer are equivalent: An analysis of 196 patients at a single, high volume institution. J Surg Oncol. 2021 Feb; 123(2):570-578.
    View in: PubMed
    Score: 0.058
  42. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg. 2000 Dec; 70(6):1826-31.
    View in: PubMed
    Score: 0.058
  43. Analysis of Lymph Node Sampling Minimums in Early Stage Non-Small-Cell Lung Cancer. Semin Thorac Cardiovasc Surg. 2021; 33(3):834-845.
    View in: PubMed
    Score: 0.058
  44. Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer. J Thorac Dis. 2020 Mar; 12(3):217-222.
    View in: PubMed
    Score: 0.055
  45. New surgical options for elderly lung cancer patients. Chest. 1999 Dec; 116(6 Suppl):480S-485S.
    View in: PubMed
    Score: 0.054
  46. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
    View in: PubMed
    Score: 0.049
  47. Pneumonectomy is safe and effective for non-small cell lung cancer following induction therapy. J Thorac Dis. 2017 Nov; 9(11):4447-4453.
    View in: PubMed
    Score: 0.047
  48. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. BMC Cancer. 2016 07 13; 16:468.
    View in: PubMed
    Score: 0.043
  49. Thirty-Day Mortality After Lobectomy in Elderly Patients Eligible for Lung Cancer Screening. Ann Thorac Surg. 2016 Feb; 101(2):541-6.
    View in: PubMed
    Score: 0.041
  50. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (=2 cm) non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1169-75; discussion 1175-7.
    View in: PubMed
    Score: 0.036
  51. Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg. 2013 May; 148(5):440-6.
    View in: PubMed
    Score: 0.034
  52. Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer. Oncologist. 2013; 18(3):281-7.
    View in: PubMed
    Score: 0.034
  53. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011 Nov; 92(5):1819-23; discussion 1824-5.
    View in: PubMed
    Score: 0.031
  54. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2011 Aug; 40(2):298-303.
    View in: PubMed
    Score: 0.030
  55. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer. 2010 Mar 15; 116(6):1510-7.
    View in: PubMed
    Score: 0.028
  56. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009 Aug; 138(2):405-11.
    View in: PubMed
    Score: 0.027
  57. Gastrointestinal complications after lung transplantation. J Heart Lung Transplant. 2009 May; 28(5):475-9.
    View in: PubMed
    Score: 0.026
  58. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2009 Feb; 137(2):453-8.
    View in: PubMed
    Score: 0.026
  59. Prostate biopsy: past, present, and future. Urology. 2007 Mar; 69(3):413-6.
    View in: PubMed
    Score: 0.022
  60. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol. 2006 Apr 01; 24(10):1561-7.
    View in: PubMed
    Score: 0.021
  61. Lung resection in patients with preoperative FEV1 < 35% predicted. Chest. 2005 Jun; 127(6):1984-90.
    View in: PubMed
    Score: 0.020
  62. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004 Jul; 128(1):138-46.
    View in: PubMed
    Score: 0.019
  63. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg. 2003 Dec; 76(6):1789-95.
    View in: PubMed
    Score: 0.018
  64. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. J Clin Oncol. 2003 Sep 01; 21(17):3343-50.
    View in: PubMed
    Score: 0.018
  65. Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol. 2003 Feb 15; 21(4):624-30.
    View in: PubMed
    Score: 0.017
  66. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg. 2001 Dec; 72(6):1918-24; discussion 1924-5.
    View in: PubMed
    Score: 0.016
  67. Surveillance transbronchial lung biopsies: implication for survival after lung transplantation. J Thorac Cardiovasc Surg. 2000 Jan; 119(1):27-37.
    View in: PubMed
    Score: 0.014
  68. Management of the solitary pulmonary nodule: role of thoracoscopy in diagnosis and therapy. Chest. 1999 Dec; 116(6 Suppl):523S-524S.
    View in: PubMed
    Score: 0.014
  69. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan; 117(1):54-63; discussion 63-5.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.